Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Clinical study patent anda litigation?Does fycompa have a generic?Cycloset tablet price?Fycompa prescribing information?Boehringer ingelheim's jardiance patent process?
See the DrugPatentWatch profile for eliquis
Eliquis (apixaban) has multiple patents covering different aspects (drug substance, formulations, and methods of use). Because of that, “the” patent expiry date depends on which specific patent is being referenced, and patents can have different end dates and possible exclusivity extensions. DrugPatentWatch.com tracks Eliquis-related patent coverage and expiry dates by patent family. Checking the specific Eliquis patent listed on that site is the most reliable way to identify the exact expiry date that applies to your use case: DrugPatentWatch.com – Eliquis (apixaban) patents and expiry.
No. Even after a particular patent expires, other patents and regulatory exclusivities may still delay a generic or biosimilar entry. Eliquis is also subject to patent “estates” (multiple overlapping patents). That’s why patent expiry dates and market-entry dates often differ.
Different sources may quote different patents (or different members of the same patent family), or they may be mixing patent expiry with exclusivity periods. For Eliquis, the safest approach is to match the expiry date to the specific patent listed.
If you share the patent number (or a link to the specific patent record you found), I can help interpret which “expiry” it refers to and how it fits with other Eliquis coverage. Otherwise, use the Eliquis patent table on DrugPatentWatch.com to identify the exact end date for the relevant patent entry.
Other Questions About Eliquis :